Judge Denied Gerber Motion in Antitrust Lawsuit
A federal judge ruled that antitrust claims regarding Gerber's infant formula plant sale may proceed to trial.
Updated on Sept. 18, 2026 in Consumer Goods
Live Poll
Should federal regulators more aggressively block mergers that could limit competition in essential markets?
Judge Nina Gershon denied a motion to dismiss antitrust claims filed by P&L Development against Gerber. The lawsuit centers on Gerber's sale of its only U.S. infant formula plant in Wisconsin to Perrigo.
Why it matters
The litigation alleges that Gerber's sale of its manufacturing facility was designed to entrench Perrigo's market power. By allowing the suit to proceed, the court is investigating whether the deal created illegal barriers for competitors.
The litigation concerns the divestiture of Gerber's singular infant formula manufacturing facility in Wisconsin. The court is now evaluating claims that this specific transaction increased market entry barriers.
The players
Nina Gershon
She is a United States District Judge for the Eastern District of New York who presided over the antitrust motion.
Gerber
This is a prominent manufacturer of infant nutrition and formula products in the United States.
P&L Development
This is a company that initiated legal action against Gerber, alleging anticompetitive behavior.
Perrigo
This is a major consumer goods company that acquired Gerber's Wisconsin infant formula production facility.
The details
P&L Development filed an amended complaint alleging that the acquisition solidified Perrigo's dominance in the infant formula sector. Judge Gershon's decision ensures that these competitive concerns will be scrutinized further in court.
Timeline
Judge Nina Gershon issued the ruling on September 18, 2026.
Market Landscape
This case highlights the increasing regulatory scrutiny applied to mergers and divestitures that consolidate manufacturing capacity. It follows the pattern of federal enforcement actions under the Sherman Antitrust Act that seek to preserve competition in specialized markets.
The resolution of this lawsuit could eventually influence market competition and the variety of infant formula brands available to families. Consumers may see shifts in product pricing or availability depending on the outcome of the competition investigation.
The takeaway
Antitrust litigation in the infant formula sector highlights the complex balance between corporate consolidation and market accessibility. Stakeholders should monitor subsequent court filings for evidence regarding how the Wisconsin plant sale impacted competitor entry into the market.
Further reading
For more on shifts in the industry, visit the Consumer Goods section.
Source note: This article includes information reported by Mlex.
Live Poll
Should federal regulators more aggressively block mergers that could limit competition in essential markets?
